Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats

Brain Research

Volumn 1334, Issue , 2010, Pages 58-64

  Safar, Marwa M ^a   Abdallah, Dalaal M ^a   Arafa, Nadia M ^b   Abdel Aziz, Mohamed T ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

Author keywords

Amino acids; Convulsions; Magnesium; Oxidative stress; Pentylenetetrazol; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID DERIVATIVE; ASPARTIC ACID; GLUTAMIC ACID; GLUTATHIONE; GLYCINE; MAGNESIUM ASPARTATE; NITRIC OXIDE; PENTETRAZOLE; TAURINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; LATENT PERIOD; MALE; NEUROMODULATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TREATMENT DURATION;

ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; GLUTATHIONE; LIPID PEROXIDATION; MAGNESIUM; MALE; NITRIC OXIDE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; REACTION TIME; SEIZURES; STATISTICS, NONPARAMETRIC; VALPROIC ACID;

RATTUS;

EID: 77952100708     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.076     Document Type: Article

References (57)

1. Abe K., Nakanishi K., and Saito H. The anticonvulsive effect of glutathione in mice. Biol. Pharm. Bull. 22 (1999) 1177-1179
2. Afanas'ev I.B., Suslova T.B., Cheremisina Z.P., Abramova N.E., and Korkina L.G. Study of antioxidant properties of metal aspartates. Analyst 120 (1995) 859-862
3. Altura B.M., Gebrewold A., Zhang A., and Altura B.T. Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. Neurosci. Lett. 341 (2003) 189-192
4. Ariza A.C., Bobadilla N., Fernandez C., Munoz-Fuentes R.M., Larrea F., and Halhali A. Effects of magnesium sulfate on lipid peroxidation and blood pressure regulators in preeclampsia. Clin. Biochem. 38 (2005) 128-133
5. Bannai S., and Kitamura E. Transport interaction of l-cystine and l-glutamate in human diploid fibroblasts in culture. J. Biol. Chem. 255 (1980) 2372-2376
6. Bashkatova V., Narkevich V., Vitskova G., and Vanin A. The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 487-492
7. Beutler E., Duron O., and Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61 (1963) 882-888
8. Bikjdaouene L., Escames G., Leon J., Ferrer J.M., Khaldy H., Vives F., and Acuna-Castroviejo D. Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures. J. Pineal Res. 35 (2003) 54-60
9. Bikjdaouene L., Escames G., Camacho E., Leon J., Ferrer J.M., Espinosa A., Gallo M.A., De Dios Luna J., and Acuna-Castroviejo D. Effects of some synthetic kynurenines on brain amino acids and nitric oxide after pentylenetetrazole administration to rats. J. Pineal Res. 36 (2004) 267-277
10. Bloom F.E. Neurotransmitters, Overview. In: Martini L. (Ed). Encyclopedia of endocrine diseases Vol. 3 (2004), Elsevier Academic Press, Boston 350-356
11. Borowicz K.K., Gasior M., Kleinrok Z., and Czuczwar S.J. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia 37 (1996) 618-624
12. Bussiere F.I., Gueux E., Rock E., Girardeau J.P., Tridon A., Mazur A., and Rayssiguier Y. Increased phagocytosis and production of reactive oxygen species by neutrophils during magnesium deficiency in rats and inhibition by high magnesium concentration. Br. J. Nutr. 87 (2002) 107-113
13. Bussiere F.I., Gueux E., Rock E., Mazur A., and Rayssiguier Y. Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur. J. Nutr. 41 (2002) 197-202
14. Cao H.Y., Jiang Y.W., Liu Z.W., and Wu X.R. Effect of recurrent epileptiform discharges induced by magnesium-free treatment on developing cortical neurons in vitro. Brain Res. Dev. Brain Res. 142 (2003) 1-6
15. Chauhan U.P., and Sarkar B.C. Use of calmagite for the determination of traces of magnesium in biological materials. Anal. Biochem. 32 (1969) 70-80
16. Cui J., Shao L., Young L.T., and Wang J.F. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144 (2007) 1447-1453
17. Czechowska G., Dziki M., Pietrasiewicz T., Kleinrok Z., Turski W.A., and Czuczwar S.J. Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice. Eur. J. Pharmacol. 232 (1993) 59-64
18. Czeh G., and Somjen G.G. Changes in extracellular calcium and magnesium and synaptic transmission in isolated mouse spinal cord. Brain Res. 486 (1989) 274-285
19. Dharnidharka V.R., and Carney P.R. Isolated idiopathic hypomagnesemia presenting as aphasia and seizures. Pediatr. Neurol. 33 (2005) 61-65
20. Djukic-Cosic D., Ninkovic M., Malicevic Z., Plamenac-Bulat Z., and Matovic V. Effect of supplemental magnesium on the kidney levels of cadmium, zinc, and copper of mice exposed to toxic levels of cadmium. Biol. Trace Elem. Res. 114 (2006) 281-291
21. Feng Y., LeBlanc M.H., and Regunathan S. Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci. Lett. 390 (2005) 129-133
22. Fueta Y., Siniscalchi A., Tancredi V., and Avoli M. Extracellular magnesium and anticonvulsant effects of valproate in young rat hippocampus. Epilepsia 36 (1995) 404-409
23. Gathwala G. Neuronal protection with magnesium. Indian J. Pediatr. 68 (2001) 417-419
24. Hamed S.A., Hamed E.A., Hamdy R., and Nabeshima T. Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 74 (2007) 183-192
25. Hans C.P., Chaudhary D.P., and Bansal D.D. Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes. Res. 16 (2003) 13-19
26. Heinrikson R.L., and Meredith S.C. Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal. Biochem. 136 (1984) 65-74
27. Ilhan A., Iraz M., Gurel A., Armutcu F., and Akyol O. Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochem. Res. 29 (2004) 2287-2292
28. Ilhan A., Aladag M.A., Kocer A., Boluk A., Gurel A., and Armutcu F. Erdosteine ameliorates PTZ-induced oxidative stress in mice seizure model. Brain Res. Bull. 65 (2005) 495-499
29. Ilhan A., Iraz M., Kamisli S., and Yigitoglu R. Pentylenetetrazol-induced kindling seizure attenuated by Ginkgo biloba extract (EGb 761) in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1504-1510
30. Kaminski R.M., Mazurek M., Turski W.A., Kleinrok Z., and Czuczwar S.J. Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacol. Biochem. Behav. 68 (2001) 661-668
31. Kondziella D., Bidar A., Urfjell B., Sletvold O., and Sonnewald U. The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: behavior and metabolism. Neurochem. Int. 40 (2002) 413-418
32. Koracevic D., Koracevic G., Djordjevic V., Andrejevic S., and Cosic V. Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol. 54 (2001) 356-361
33. Kuzniar A., Mitura P., Kurys P., Szymonik-Lesiuk S., Florianczyk B., and Stryjecka-Zimmer M. The influence of hypomagnesemia on erythrocyte antioxidant enzyme defence system in mice. Biometals 16 (2003) 349-357
34. Lang-Lazdunski L., Heurteaux C., Dupont H., Widmann C., and Lazdunski M. Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole. J. Vasc. Surg. 32 (2000) 179-189
35. Li Z., Yamamoto Y., Morimoto T., Ono J., Okada S., and Yamatodani A. The effect of pentylenetetrazole-kindling on the extracellular glutamate and taurine levels in the frontal cortex of rats. Neurosci. Lett. 282 (2000) 117-119
36. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
37. Loscher W. Relationship between drug-induced changes in seizure thresholds and the GABA content of brain and brain nerve endings. Naunyn-Schmiedebergs Arch. Pharmacol. 317 (1981) 131-134
38. Loscher W. In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of rats. Neurosci. Lett. 160 (1993) 177-180
39. McCandless D.M., and Schwartzenburg Jr. F.C. Pentylenetetrazole induced changes in cerebellar energy metabolism. Neurochem. Res. 7 (1982) 811-819
40. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
41. Mills B.J., Lindeman R.D., and Lang C.A. Magnesium deficiency inhibits biosynthesis of blood glutathione and tumor growth in the rat. Proc. Soc. Exp. Biol. Med. 181 (1986) 326-332
42. Minnich V., Smith M.B., Brauner M.J., and Majerus P.W. Glutathione biosynthesis in human erythrocytes. I. Identification of the enzymes of glutathione synthesis in hemolysates. J. Clin. Invest. 50 (1971) 507-513
43. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62-71
44. Patsoukis N., Zervoudakis G., Georgiou C.D., Angelatou F., Matsokis N.A., and Panagopoulos N.T. Effect of pentylenetetrazol-induced epileptic seizure on thiol redox state in the mouse cerebral cortex. Epilepsy Res. 62 (2004) 65-74
45. Patsoukis N., Zervoudakis G., Panagopoulos N.T., Georgiou C.D., Angelatou F., and Matsokis N.A. Thiol redox state (TRS) and oxidative stress in the mouse hippocampus after pentylenetetrazol-induced epileptic seizure. Neurosci. Lett. 357 (2004) 83-86
46. Patsoukis N., Zervoudakis G., Georgiou C.D., Angelatou F., Matsokis N.A., and Panagopoulos N.T. Thiol redox state and lipid and protein oxidation in the mouse striatum after pentylenetetrazol-induced epileptic seizure. Epilepsia 46 (2005) 1205-1211
47. Rajasekaran K. Seizure-induced oxidative stress in rat brain regions: blockade by nNOS inhibition. Pharmacol. Biochem. Behav. 80 (2005) 263-272
48. Rajasekaran K., Jayakumar R., and Venkatachalam K. Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Res. 979 (2003) 85-97
49. Regan R.F., Jasper E., Guo Y., and Panter S.S. The effect of magnesium on oxidative neuronal injury in vitro. J. Neurochem. 70 (1998) 77-85
50. Rothman S.M., and Olney J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18 (1995) 57-58
51. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
52. Sood A.K., Handa R., Malhotra R.C., and Gupta B.S. Serum, CSF, RBC & urinary levels of magnesium & calcium in idiopathic generalised tonic clonic seizures. Indian J. Med. Res. 98 (1993) 152-154
53. Sudha K., Rao A.V., and Rao A. Oxidative stress and antioxidants in epilepsy. Clin. Chim. Acta 303 (2001) 19-24
54. Theodore W.H., and Fisher R. Brain stimulation for epilepsy. Acta Neurochir. Suppl. 97 (2007) 261-272
55. Turkoglu O.F., Eroglu H., Okutan O., Tun M.K., Bodur E., Sargon M.F., Oner L., and Beskonakli E. A comparative study of treatment for brain edema: magnesium sulphate versus dexamethasone sodium phosphate. J. Clin. Neurosci. 15 (2008) 60-65
56. Uma Devi P., Pillai K.K., and Vohora D. Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine. Fundam. Clin. Pharmacol. 20 (2006) 247-253
57. Ustun M.E., Gurbilek M., Ak A., Vatansev H., and Duman A. Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med. 27 (2001) 264-268